• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS PARIETENE; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION SAS PARIETENE; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number PP1510X3C
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Adhesion(s) (1695); Emotional Changes (1831); Inflammation (1932); Muscle Weakness (1967); Pain (1994); Scar Tissue (2060); Hernia (2240); Anxiety (2328); Discomfort (2330); Depression (2361); Obstruction/Occlusion (2422); Unspecified Tissue Injury (4559); Swelling/ Edema (4577); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Manufacturer Narrative
Concomitant product: pnp8x3 parietex plug and patch 8 cm cir x3 (lot# sqb0413x).If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an inguinal hernia.It was reported that after the implant, the patient experienced pain, inflammation, swelling, bowel obstruction, gastrointestinal malfunction, loss of enjoyment of life, loss of ability to participate in regular/normal activates, and hernia recurrence,.Post-operative patient treatment included reparative surgery, hospitalization, diagnostic imaging, revision surgery, serum testing, antibiotics, analgesics, medication, therapy, and rehabilitation.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Additional info: h6 (patient and health impact codes; e2402: capsular hypertrophy, fluid between symphysis and tendon).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
The patient¿s attorney alleged a deficiency against the device.The product was used for laparoscopic therapeutic treatment of an inguinal hernia.It was reported that after the implant, the patient experienced adhesions, discomfort, fullness, firmness, scarring, anxiety, depression, capsular hypertrophy, fluid between symphysis and tendon, partial avulsion of rectus abdominis tenon/rectus abdominis aponeurosis, pain, inflammation, swelling, bowel obstruction, gastrointestinal malfunction, loss of enjoyment of life, loss of ability to participate in regular/normal activates, and hernia recurrence.Post-operative patient treatment included hernia repair with mesh, pain medications, medications for anxiety/depression, physiotherapy, ultrasound, mri, ct, reparative surgery, hospitalization, diagnostic imaging, revision surgery, serum testing, antibiotics, analgesics, medication, therapy, and rehabilitation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PARIETENE
Type of Device
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR  01600
Manufacturer (Section G)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR   01600
Manufacturer Contact
justin ellis
8200 coral sea st ne
mounds view,mn, CO 55112
7635265677
MDR Report Key12623971
MDR Text Key276145952
Report Number9615742-2021-02277
Device Sequence Number1
Product Code FTL
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 02/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/13/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2020
Device Model NumberPP1510X3C
Device Catalogue NumberPP1510X3C
Device Lot NumberSPI0451X
Was Device Available for Evaluation? No
Date Manufacturer Received02/13/2023
Date Device Manufactured09/30/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PROTACK TACKER, LOT: P5K0508X, PRODUCT ID: 174006.; SEE SECTION H10.
Patient Outcome(s) Hospitalization; Disability; Required Intervention;
Patient Age44 YR
-
-